These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Vaccines for human malaria: epidemiological and immunological perspectives. Webster HK; Diggs CL; Ballou WR; Chulay JD Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):375-89. PubMed ID: 3064321 [No Abstract] [Full Text] [Related]
4. Towards a malaria vaccine: what is in sight? del Giudice G Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171 [No Abstract] [Full Text] [Related]
5. Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum. Lupski JR N Engl J Med; 1987 Feb; 316(7):415. PubMed ID: 3100954 [No Abstract] [Full Text] [Related]
8. [Current state of the studies of malaria vaccine]. Dzbeński TH Przegl Epidemiol; 1990; 44(3):173-8. PubMed ID: 2084799 [No Abstract] [Full Text] [Related]
9. The malaria sporozoite vaccine: parasitology's brave new world. Spriggs DR J Infect Dis; 1985 Sep; 152(3):655-6. PubMed ID: 2411830 [No Abstract] [Full Text] [Related]
10. Plasmodium falciparum antigens as target molecules for a protective immunization against malaria: an up-to-date review. Heidrich HG Z Parasitenkd; 1986; 72(1):1-11. PubMed ID: 3515789 [No Abstract] [Full Text] [Related]
11. Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum. Hoffman SL; Wistar R; Ballou WR; Hollingdale MR; Wirtz RA; Schneider I; Marwoto HA; Hockmeyer WT N Engl J Med; 1986 Sep; 315(10):601-6. PubMed ID: 3526148 [TBL] [Abstract][Full Text] [Related]
12. Development of asexual blood stage malaria vaccines. Kidson C Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):391-6. PubMed ID: 3064322 [No Abstract] [Full Text] [Related]
13. [Can malaria be eradicated by vaccination?]. Stürchler D Schweiz Rundsch Med Prax; 1987 Sep; 76(36):975-80. PubMed ID: 3310179 [No Abstract] [Full Text] [Related]
14. Potential vaccine antigens of the asexual blood-stages of Plasmodium falciparum. Anders RF; Brown GV; Coppel RL; Stahl HD; Bianco AE; Favaloro JM; Crewther PE; Culvenor JG; Kemp DJ Dev Biol Stand; 1985; 62():81-9. PubMed ID: 2422079 [TBL] [Abstract][Full Text] [Related]
15. Development of a sporozoite malaria vaccine. Nussenzweig V; Nussenzweig RS Am J Trop Med Hyg; 1986 Jul; 35(4):678-88. PubMed ID: 2425647 [No Abstract] [Full Text] [Related]
16. [Vaccination against malaria: current status and perspectives]. Dubois P; Pereira da Silva L Rev Prat; 1988 Jun; 38(18):1173-7. PubMed ID: 3051302 [No Abstract] [Full Text] [Related]
17. Induction of protective immunity to malaria. Anders RF; Brown GV; Coppel RL; Kemp DJ Lepr Rev; 1986 Dec; 57 Suppl 2():245-53. PubMed ID: 3553798 [No Abstract] [Full Text] [Related]
18. Malaria vaccines: experience with sporozoite vaccines against falciparum malaria. Levine MM; Herrington D; Clyde D; Murphy J; Davis J; Nussenzweig R; Nardin E; Felix A; Heimer E; Gillesen D Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):369-74. PubMed ID: 3064320 [No Abstract] [Full Text] [Related]
19. The circumsporozoite protein gene from NF54, a Plasmodium falciparum isolate used in malaria vaccine trials. Caspers P; Gentz R; Matile H; Pink JR; Sinigaglia F Mol Biochem Parasitol; 1989 Jun; 35(2):185-9. PubMed ID: 2671723 [No Abstract] [Full Text] [Related]